12.09.2025
cellvie, a pioneer in mitochondrial-based therapeutics, has secured fresh funding from both existing and new investors. With the additional capital, cellvie will accelerate the clinical translation of its lead program in kidney transplantation, and to further hone its pipeline.
04.07.2025
Twenty-three startups, among them our resident Arbrea Labs, made it to the second phase of Innosuisse’s Scale-up Coaching program, unlocking an additional voucher of up to CHF 75’000 that can be redeemed for further coaching sessions. The companies are developing solutions across a range of industries, including medtech, ICT, industrial machinery and cleantech.
21.05.2025
Nanoflex Robotics AG has secured the prestigious 2025 ZKB Pionierpreis Technopark, a leading Swiss deeptech innovation award, for its cutting-edge telerobotic technology designed to revolutionize endovascular interventions. Competing against two formidable finalists – LegalTech innovator Ex Nunc Intelligence from Lausanne and Zurich-based infrastructure monitoring specialist Irmos Technologies – the Glattbrugg-based MedTech startup emerged as this […]
21.05.2025
Nanoflex Robotics AG was honored with the jury prize and the audience award for its cutting-edge telerobotic technology designed to revolutionize endovascular interventions – in particular stroke treatment – by reducing the risks of trauma and complications. The system also allows remote surgeries. Zum Beitrag auf Startupticker
30.04.2025
As part of a strategic move to diversify international engagement beyond traditional markets like the EU and the U.S., the Technopark Alliance – a consortium of 8 Technoparks across Switzerland and Liechtenstein – partnered with Succeed Consulting and Venturelab to launch a forward-looking initiative. China – and in particular Zhejiang Province – is rapidly emerging […]